
Ticabrel 90mg Tablet
Marketer
Prevego Healthcare & Research Private Limited
Salt Composition
Ticagrelor (90mg)
Overview Ticabrel 90mg Tablet
CardioGuard 90mg tablets are classified as antiplatelet agents, effectively reducing the risk of dangerous blood clot formation within blood vessels. This preventative action lowers the likelihood of heart attack or stroke in individuals with pre-existing cardiac conditions. CardioGuard 90mg is also indicated for patients recovering from a recent heart attack, experiencing severe angina (unstable chest pain), or who have received cardiac stenting. Its use helps mitigate the risk of future cardiac events, including recurrent heart attack, stroke, or stent thrombosis. Concomitant use with aspirin, another antiplatelet medication, will typically be prescribed by your physician. CardioGuard 90mg may be administered with or without food, consistently at the same time daily. Continued use is crucial, even in the absence of symptoms; discontinuation increases the risk of cardiovascular complications. While bleeding is the most frequent side effect, usually resolving spontaneously, prolonged or excessive bleeding should be reported. Similarly, although mild shortness of breath may occur, persistent or worsening dyspnea requires medical attention. CardioGuard 90mg is contraindicated in patients with active internal bleeding (e.g., stomach ulcers, intracranial hemorrhage) or liver disease. Always disclose any such conditions to your physician before commencing treatment.
Primary Ingredients of Ticabrel 90mg Tablet
No text provided. Please provide the text you wish me to rephrase.
Uses of Ticabrel 90mg Tablet
Reducing the risk of cardiovascular events
Major Benefits of Ticabrel 90mg Tablet:
Administer this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Ticabrel 90mg Tablets can be consumed with or without food, although consistent timing is recommended.
Common Side effects of Ticabrel 90mg Tablet:
- Bleeding
- Breathlessness
How to use Ticabrel 90mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the 90mg Ticabrel tablet whole; avoid chewing, crushing, or breaking it. While you can take it with or without food, consistent timing is recommended.
How Ticabrel 90mg Tablet works:
Ticagrelor 90mg tablets inhibit platelet aggregation, a process crucial in blood clot formation. By preventing platelets from clumping, this medication reduces the risk of cardiovascular events such as stroke and myocardial infarction.
SAFETY ADVICE
AlcoholCAUTION
Use caution when combining alcohol and Ticabrel 90mg tablets. Seek medical advice before doing so.
PregnancyCONSULT YOUR DOCTOR
Use of Ticabrel 90mg tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Ticabrel 90mg tablets with breastfeeding are currently unavailable. Seek medical advice from your physician.
DrivingSAFE
Driving ability is typically unaffected by Ticabrel 90mg Tablets.
KidneySAFE IF PRESCRIBED
Ticabrel 90mg tablets are considered safe for individuals with kidney impairment; no dosage modification is advised. Data regarding Ticabrel 90mg tablet use in patients undergoing renal dialysis is currently limited.
LiverCAUTION
Patients with liver impairment should use Ticabrel 90mg tablets cautiously, potentially requiring dose modification. Severe liver disease contraindicates the use of Ticabrel 90mg tablets; physician consultation is advised.
What if you forget to take Ticabrel 90mg Tablet :
Should you forget a Ticabrel 90mg Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Ticabrel 90mg Tablet
| Label | Value |
|---|---|
| Chemical Classification | Triazolo[1,5-a]pyrimidines |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Actions | ADP receptor antagonists (P2Y12 inhibitors) |
